Início › Carcinoma de Células Escamosas de Cabeça e Pescoço › Tennessee › Nashville
Ensaios clínicos de Carcinoma de Células Escamosas de Cabeça e Pescoço em Nashville, TN
39 estudos para Carcinoma de Células Escamosas de Cabeça e Pescoço estão buscando participantes em locais em Nashville e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecrutandoFase 1
- Vanderbilt University Medical Center, Nashville
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RecrutandoFase 2/3
- Site#0126, Nashville
- Site #0116, Nashville
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #3, Nashville
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecrutandoFase 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecrutandoFase 1
- Research Site, Nashville
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RecrutandoFase 3
- Vanderbilt University Medical Center, Nashville
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecrutandoFase 1/2
- Vanderbilt University Medical Center, Nashville
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
RecrutandoFase 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecrutandoFase 1
- Sarah Cannon - Tennessee Oncology, Nashville
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RecrutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecrutandoFase 1/2
- Sarah Cannon Nashville, Nashville
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
RecrutandoFase 1
- Sarah Cannon and HCA Research Institute, Nashville
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RecrutandoEstudo observacional
- Vanderbilt University, Nashville
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RecrutandoFase 2
- Vanderbilt-Ingram Cancer Center, Nashville
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RecrutandoFase 1
- Normunity Investigational Site, Nashville
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- Vanderbilt University Medical Center, Nashville
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RecrutandoFase 2/3
- Vanderbilt University/Ingram Cancer Center, Nashville
SMP-3124LP in Adults With Advanced Solid Tumors
RecrutandoFase 1/2
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecrutandoFase 1/2
- SCRI Oncology Partners, Nashville
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
RecrutandoFase 1
- Vanderbilt University Medical Center, Nashville
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecrutandoFase 1
- Tennessee Oncology, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
RecrutandoFase 1
- Vanderbilt University Medical Center, Nashville
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecrutandoFase 1
- US Oncology Research LLC, Nashville
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecrutandoFase 1
- SCRI Oncology Partners, Nashville
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
RecrutandoFase 3
- GSK Investigational Site, Nashville
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
RecrutandoFase 1
- Vanderbilt University Medical Center, Nashville
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Recrutando
- Vanderbilt University Medical Center, Nashville
(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
RecrutandoFase 1
- Vanderbilt University/Ingram Cancer Center, Nashville
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Recrutando
- Vanderbilt-Ingram Cancer Center, Nashville
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RecrutandoFase 1/2
- Tennessee Oncology, PLLC, Nashville
Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
RecrutandoFase 1
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecrutandoFase 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecrutandoFase 1/2
- Research Site 136, Nashville
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Nashville
- Veterans Affairs Medical Center - Nashville, Nashville
- e mais 1
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
RecrutandoFase 1
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RecrutandoFase 1/2
- Tennessee Oncology, Nashville
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
RecrutandoFase 1 inicial
- Vanderbilt University/Ingram Cancer Center, Nashville
Ensaios de Carcinoma de Células Escamosas de Cabeça e Pescoço em outras cidades
- Houston, TX47 estudos
- Los Angeles, CA42 estudos
- Boston, MA40 estudos
- New York City, NY39 estudos
- St. Louis, MO28 estudos
- Arlington, VA26 estudos
- Chicago, IL26 estudos
- Philadelphia, PA25 estudos
- Atlanta, GA24 estudos
- San Antonio, TX22 estudos
- Pittsburgh, PA22 estudos
- New Haven, CT22 estudos
Outros estudos em Nashville
- Câncer de Pulmão de Não Pequenas Células97 estudos
- Câncer de Mama80 estudos
- Câncer Metastático70 estudos
- Câncer Colorretal69 estudos
- Câncer (todos os tipos)65 estudos
- Câncer de Ovário49 estudos
- Câncer de Próstata43 estudos
- Câncer de Pulmão40 estudos
- Câncer de Pâncreas39 estudos
- Câncer Endometrial38 estudos
- Melanoma33 estudos
- Mieloma Múltiplo32 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 7 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.